Schonfeld Strategic Advisors’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,581
| Closed | -$550K | – | 2202 |
|
|
2025
Q4 | $550K | Sell |
2,581
-35,669
| -93% | -$7.37M | ﹤0.01% | 1362 |
|
|
2025
Q3 | $7.6M | Buy |
38,250
+36,379
| +1,944% | +$6.79M | 0.05% | 433 |
|
|
2025
Q2 | $323K | Sell |
1,871
-58,504
| -97% | -$9.53M | ﹤0.01% | 1673 |
|
|
2025
Q1 | $9.41M | Sell |
60,375
-78,218
| -56% | -$11.2M | 0.06% | 344 |
|
|
2024
Q4 | $19.1M | Sell |
138,593
-89,932
| -39% | -$11.8M | 0.12% | 164 |
|
|
2024
Q3 | $34.1M | Buy |
228,525
+130,384
| +133% | +$17.6M | 0.28% | 56 |
|
|
2024
Q2 | $13.4M | Sell |
98,141
-3,859
| -4% | -$525K | 0.1% | 270 |
|
|
2024
Q1 | $15.4M | Sell |
102,000
-22,901
| -18% | -$3.27M | 0.12% | 234 |
|
|
2023
Q4 | $15.7M | Buy |
124,901
+86,001
| +221% | +$8.57M | 0.13% | 225 |
|
|
2023
Q3 | $3.64M | Buy |
38,900
+7,700
| +25% | +$720K | 0.03% | 640 |
|
|
2023
Q2 | $2.78M | Buy |
31,200
+10,300
| +49% | +$896K | 0.02% | 650 |
|
|
2023
Q1 | $2.24M | Sell |
20,900
-46,958
| -69% | -$5.37M | 0.02% | 661 |
|
|
2022
Q4 | $8.29M | Buy |
67,858
+52,358
| +338% | +$6.08M | 0.07% | 347 |
|
|
2022
Q3 | $1.6M | Buy |
+15,500
| New | +$1.47M | 0.01% | 980 |
|
|
2022
Q1 | – | Sell |
-12,800
| Closed | -$1.72M | – | 2582 |
|
|
2021
Q4 | $1.72M | Buy |
+12,800
| New | +$1.9M | 0.02% | 743 |
|
|
2021
Q3 | – | Sell |
-13,900
| Closed | -$1.83M | – | 2148 |
|
|
2021
Q2 | $1.83M | Buy |
13,900
+5,800
| +72% | +$773K | 0.02% | 744 |
|
|
2021
Q1 | $1.04M | Sell |
8,100
-16,520
| -67% | -$2.51M | 0.01% | 873 |
|
|
2020
Q4 | $4.11M | Sell |
24,620
-3,295
| -12% | -$545K | 0.06% | 442 |
|
|
2020
Q3 | $4.31M | Buy |
27,915
+13,415
| +93% | +$1.93M | 0.09% | 329 |
|
|
2020
Q2 | $2.14M | Buy |
+14,500
| New | +$1.99M | 0.06% | 388 |
|
|
2020
Q1 | – | Sell |
-11,400
| Closed | -$1.59M | – | 1131 |
|
|
2019
Q4 | $1.59M | Sell |
11,400
-28,400
| -71% | -$3.16M | 0.04% | 386 |
|
|
2019
Q3 | $3.83M | Sell |
39,800
-51,700
| -57% | -$5.77M | 0.11% | 200 |
|
|
2019
Q2 | $10.5M | Sell |
91,500
-92,900
| -50% | -$11.1M | 0.37% | 64 |
|
|
2019
Q1 | $21.7M | Buy |
+184,400
| New | +$16.1M | 0.75% | 16 |
|
|
2018
Q3 | – | Sell |
-15,000
| Closed | -$997K | – | 797 |
|
|
2018
Q2 | $997K | Buy |
+15,000
| New | +$986K | 0.05% | 392 |
|
|
2017
Q4 | – | Sell |
-9,763
| Closed | -$354K | – | 738 |
|
|
2017
Q3 | $354K | Buy |
+9,763
| New | +$280K | 0.03% | 428 |
|
Other funds holding ASND
RCM
ACA
